Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Rupesh Kotecha

Dr. Rupesh Kotecha

Radiation Oncologist

Dr. Rupesh Kotecha is a highly regarded and board-certified radiation oncologist at Miami Cancer Institute treating lung, breast, brain, esophageal and other cancers. His research has focused on treating patients with radiosurgery and stereotactic body radiation therapy.

Get in touch
Jump to a Topic:

About Rupesh Kotecha

Accolades
  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Research Excellence icon

    Excellence in Research

  • Board Certified icon

    Board Certified in Radiation Oncology

  • 10+ Years of Experience icon

    10+ Years of Experience

Get to Know Dr. Rupesh Kotecha

Dr. Rupesh Kotecha has training and expertise in the latest radiation technology, including state-of-the-art pencil-beam proton therapy, added recently at the Miami Cancer Institute. Kotecha also has a particular interest in stereotactic radiosurgery for managing brain metastases, which has improved patients’ quality of life.

He has taken leadership in using the innovative Tumor Treating Fields, a non-invasive therapy that utilizes low-voltage electric fields and works by disrupting cancer cell division. Kotecha was one of the first in America to use TTFields for mesothelioma traetment under the FDA’s Humanitarian Device Exemption Protocol.

He graduated from Michigan State University Medical School and completed his residency at the Cleveland Clinic.

Kotecha, who followed in his father’s medical footsteps, also is known for his patient-centered manner at the Miami Cancer Institute.

“I want patients to know as much about their cancer as I know, whether that takes 20 minutes, an hour, or three hours,” said Kotecha. “I want them to walk away feeling empowered and educated about the process.”

Specialties of Dr. Rupesh Kotecha

Dr. Rupesh Kotecha’s Experience and Medical Education

  • Michigan State University College of Human Medicine (Medical school)

  • Michigan State University Honors College

  • Department of Radiology and Department of Hematology/Oncology, Children’s Hospital Los Angeles (Research fellow)

  • Department of Neurology, Cincinnati Children’s Hospital Medical Center (Research fellow)

  • Cleveland Clinic Foundation, Taussig Cancer Institute (Fellowship)

Dr. Rupesh Kotecha’s Awards and Certifications

  • Helen and Verne Beilfuss Memorial Research Award for cancer-related research

  • Cleveland Clinic Educational Foundation Excellence in Teaching Award

  • ASTRO Annual Meeting Resident Abstract Award (Second place, clinical)

  • Cleveland Clinic Jerrold P. Saxton Award for Clinical Excellence

  • Board certified in radiation oncology

Mesothelioma Clinical Trials Under Rupesh Kotecha, M.D.

  • Radiation therapy alone versus radiation therapy plus radiofrequency ablation (RFA)/vertebral augmentation.

  • Determining whether durvalumab in combination with radiation therapy can prevent the progression of non-small cell lung cancer.

  • A study of olaparib and low-dose radiotherapy for small cell lung cancer.

  • Investigating the effectiveness of stereotactic body radiotherapy in addition to standard of care treatment for cancer that has spread beyond the original site of disease.

  • Effect of Tumor Treating Fields (150 kHz) concurrent with standard of care therapies for treatment of stage 4 non-small cell lung cancer following platinum failure (LUNAR).

See More Top Mesothelioma Doctors

Publications of Dr. Rupesh Kotecha

  • Mehta, M. & Kotecha, R. (2018, November 20). Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred? Journal of Clinical Oncology.

  • Parsai, S. et al. (2018, October 4). Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases. Journal of Neurosurgery.

  • Barata, P.C. et al. (2018, August 17). Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer.

  • Juloori, A. et al. (2018, August 14). Overall survival and the response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases. Journal of Neurosurgery.

  • Desai, M.Y. et al. (2018, August 11). Radiation-Associated Cardiac Disease: A Practical Approach to Diagnosis and Management. JACC Cardiovascular Imaging.

Disclaimer: Dr. Rupesh Kotecha has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Asbestos.com Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at Asbestos.com
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. BaptistHealth.net. (n.d.). About Rupesh Rajesh Kotecha.
    Retrieved from: https://doctors.baptisthealth.net/provider/Rupesh+Rajesh+Kotecha/870296
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified October 15, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now